scholarly journals White coat effect in treated versus untreated hypertensive individuals: a case-control study using ambulatory and home blood pressure monitoring

2004 ◽  
Vol 17 (2) ◽  
pp. 124-128 ◽  
Author(s):  
G Stergiou
2018 ◽  
Vol 27 (3) ◽  
pp. 151-157 ◽  
Author(s):  
Thiago Veiga Jardim ◽  
Carolina de Souza Carneiro ◽  
Polyana Morais ◽  
Vanessa Roriz ◽  
Karla Lorena Mendonça ◽  
...  

2018 ◽  
Vol 31 (8) ◽  
pp. 919-927 ◽  
Author(s):  
Eileen J Carter ◽  
Nathalie Moise ◽  
Carmela Alcántara ◽  
Alexandra M Sullivan ◽  
Ian M Kronish

Abstract BACKGROUND Guidelines recommend that patients with newly elevated office blood pressure undergo ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM) to rule-out white coat hypertension before being diagnosed with hypertension. We explored patients’ perspectives of the barriers and facilitators to undergoing ABPM or HBPM. METHODS Focus groups were conducted with twenty English- and Spanish-speaking individuals from underserved communities in New York City. Two researchers analyzed transcripts using a conventional content analysis to identify barriers and facilitators to participation in ABPM and HBPM. RESULTS Participants described favorable attitudes toward testing including readily understanding white coat hypertension, agreeing with the rationale for out-of-office testing, and believing that testing would benefit patients. Regarding ABPM, participants expressed concerns over the representativeness of the day the test was performed and the intrusiveness of the frequent readings. Regarding HBPM, participants expressed concerns over the validity of the monitoring method and the reliability of home blood pressure devices. For both tests, participants noted that out-of-pocket costs may deter patient participation and felt that patients would require detailed information about the test itself before deciding to participate. Participants overwhelmingly believed that out-of-office testing benefits outweighed testing barriers, were confident that they could successfully complete either testing if recommended by their provider, and described the rationale for their testing preference. CONCLUSIONS Participants identified dominant barriers and facilitators to ABPM and HBPM testing, articulated testing preferences, and believed that they could successfully complete out-of-office testing if recommended by their provider.


2019 ◽  
Vol 42 (11) ◽  
pp. 1816-1823 ◽  
Author(s):  
Audes D. M. Feitosa ◽  
Marco A. Mota-Gomes ◽  
Weimar S. Barroso ◽  
Roberto D. Miranda ◽  
Eduardo C. D. Barbosa ◽  
...  

2018 ◽  
Vol 20 (12) ◽  
pp. 1745-1747 ◽  
Author(s):  
Audes D. M. Feitosa ◽  
Marco A. Mota‐Gomes ◽  
Roberto D. Miranda ◽  
Weimar S. Barroso ◽  
Eduardo C. D. Barbosa ◽  
...  

2021 ◽  
Vol 33 (7-8_suppl) ◽  
pp. 40S-50S
Author(s):  
Krista R. Schaefer ◽  
Amber L. Fyfe-Johnson ◽  
Carolyn J. Noonan ◽  
Michael R. Todd ◽  
Jason G. Umans ◽  
...  

Objectives: Home blood pressure monitoring (HBPM) is an important component of blood pressure (BP) management. We assessed performance of two HBPM devices among Alaska Native and American Indian people (ANAIs). Methods: We measured BP using Omron BP786 arm cuff, Omron BP654 wrist cuff, and Baum aneroid sphygmomanometer in 100 ANAIs. Performance was assessed with intraclass correlation, paired t-tests, and calibration models. Results: Compared to sphygmomanometer, average BP was higher for wrist cuff (systolic = 4.8 mmHg and diastolic = 3.6 mmHg) and varied for arm cuff (systolic = −1.5 mmHg and diastolic = 2.5 mmHg). Calibration increased performance from grade B to A for arm cuff and from D to B for wrist cuff. Calibration increased false negatives and decreased false positives. Discussion: The arm HBPM device is more accurate than the wrist cuff among ANAIs with hypertension. Most patients are willing to use the arm cuff when accuracy is discussed.


Sign in / Sign up

Export Citation Format

Share Document